
Dr. Protopopescu’s presentation highlights how digitalization and artificial intelligence are transforming IVF, enabling more predictable outcomes and data-driven medical decisions.
During the IVF Conference, part of the Bucharest Leaders’ Summit: A Roadmap to the Future, Dr. Denisa Marina Protopopescu presented a clear and forward-looking perspective on how technology and artificial intelligence are shaping the future of in vitro fertilization. Her presentation highlighted the growing need for digitalization, standardization, and data-driven approaches in order to reduce variability within laboratory processes.
Dr. Protopopescu explained that many decisions in the IVF laboratory are still influenced by individual experience and visual interpretation. This can lead to variations in embryo assessment and clinical decision-making. Modern technologies — from time-lapse systems to integrated software platforms — have the capacity to transform these stages into a more predictable and scientifically grounded process.
A central theme of the presentation focused on how digitalization and automated monitoring help medical teams make more precise, data-based decisions. Dr. Protopopescu emphasized that technology does not replace the embryologist, but rather provides additional clarity and support.
Key elements include:
In this way, technology becomes a true ally of the medical team, contributing to the standardization of evaluations.
Artificial intelligence has the ability to identify subtle patterns that the human eye may overlook, offering an objective second opinion. In her talk, Dr. Protopopescu stressed that AI functions as a partner to the specialist, not as a replacement.
Mentioned benefits include:
This type of analysis provides valuable support in making critical decisions throughout the IVF process.
Dr. Protopopescu also highlighted that the effective use of artificial intelligence is only possible within a laboratory environment supported by well-structured and fully integrated data. At the same time, implementing these technologies must comply with strict ethical standards.
Key principles discussed:
Ethics and responsibility remain top priorities, especially in a field as sensitive as reproductive medicine.
Dr. Denisa Marina Protopopescu’s intervention outlined a future in which technology and artificial intelligence play an essential role in improving IVF laboratory processes. Through digitalization, standardization, and advanced data analysis, specialists can make better-informed decisions, reduce subjectivity, and offer patients a more predictable and transparent experience.
At CMIB, we align with this vision and continue to invest in innovative, scientifically validated solutions to ensure the best possible chances of success in in vitro fertilization treatments.